|
gptkbp:instanceOf
|
gptkb:chemical_compound
gptkb:sympathomimetic_amine
gptkb:beta-2_adrenergic_agonist
|
|
gptkbp:ATCCode
|
R03AC14
|
|
gptkbp:CASNumber
|
37148-27-9
|
|
gptkbp:category
|
gptkb:stimulant
gptkb:bronchodilator
gptkb:secondary_alcohol
gptkb:veterinary_medicine
gptkb:phenylethanolamine
gptkb:amphetamine
gptkb:beta-adrenergic_agonist
chlorobenzene derivative
|
|
gptkbp:chemicalFormula
|
C12H18Cl2N2O
|
|
gptkbp:discoveredBy
|
1970s
|
|
gptkbp:eliminationHalfLife
|
36-48 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:IUPACName
|
1-(4-amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol
|
|
gptkbp:KEGGID
|
D07702
|
|
gptkbp:legalStatus
|
approved for veterinary use
banned in sports
not approved for human use in the US
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
277.19 g/mol
|
|
gptkbp:notableCase
|
athletes testing positive due to contaminated meat
|
|
gptkbp:prohibits
|
gptkb:World_Anti-Doping_Agency
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1426
2783
DB01407
|
|
gptkbp:relatedTo
|
gptkb:salbutamol
gptkb:albuterol
terbutaline
|
|
gptkbp:riskFactor
|
adverse cardiovascular effects
potential for misuse in bodybuilding
|
|
gptkbp:routeOfAdministration
|
oral
inhalation
|
|
gptkbp:sideEffect
|
anxiety
headache
tachycardia
cardiac hypertrophy
muscle tremor
|
|
gptkbp:UNII
|
XT1H2FLU9B
|
|
gptkbp:used_in_veterinary_medicine_for
|
treatment of respiratory diseases in horses
|
|
gptkbp:usedFor
|
gptkb:bronchodilator
treatment of asthma
performance enhancement (illicit)
|
|
gptkbp:bfsParent
|
gptkb:34580-13-7
gptkb:14611-51-9
|
|
gptkbp:bfsLayer
|
8
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Clenbuterol
|